Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Siemens Opens Factory Outside Chicago

By Drug Discovery Trends Editor | June 27, 2012

Siemens Healthcare opened its state-of-the-art refurbished systems factory in Wood Dale, Ill. The 29,190 sq. foot facility will refurbish a broad array of previously owned Siemens medical imaging systems, including its portfolio of computed tomography (CT), magnetic resonance imaging (MRI), and molecular imaging (MI) units.

The Wood Dale factory is approximately 10,000 sq. ft. larger than Siemens’ previous Chicago-area refurbished systems facility, which has been located in nearby Hoffman Estates since October 2003. Siemens’ Wood Dale site puts the company under the same roof as its primary refurbished systems service provider, Hegele Logistic LLC.

“Our new refurbished systems factory in Wood Dale optimizes the value stream of our processes and material flow by bringing Siemens and Hegele Logistic together in one state-of-the-art facility and elevating us to a higher performance level as we continue to provide customers with Siemens’ ecoline family of premium economical and ecologically friendly refurbished systems,” says Elisabeth Staudinger, CEO of Refurbished Systems, Siemens Healthcare. “The additional square footage of the Wood Dale factory also provides Siemens with ample room for expansion as we continue to grow our thriving refurbished systems business.”

The Wood Dale factory is Siemens’ only refurbished systems facility in the U.S., which is one of the largest markets for preowned imaging systems.

Date: June 20, 2012
Source: Siemens Healthcare

 


Filed Under: Drug Discovery

 

Related Articles Read More >

Sai Life Sciences exec: GLP-1 boom has ‘exploded the peptide field’ as firm opens new center
Novartis in the Pharma 50
Swissmedic approves first malaria treatment for infants
Korean team reports all-in-one cancer nanomedicine in pre-clinical studies
Nektar’s Phase 2b atopic dermatitis win triggers 1,746% analyst target surge, but legal tussle with ex-partner Lilly could complicate path forward
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE